Christopher T Ritchlin

PubHawk tracks social media discussions for 2 articles by authors named Christopher T Ritchlin.

Claim this profile View on PubMed

Mentions

16

Peak: 4 in Apr 2024

across 2 tracked articles

Extended reach

51,334

potential audience

Total likes

21

Video views

941

Mentions per month

Feb 2023 – Oct 2024

Where it's discussed

X / Twitter11 posts
YouTube3 videos
News2 articles

Tracked by PubHawk

Most discussed articles

RMD Open Feb 2024

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL.

Laura C Coates, Robert Landewé, Iain B McInnes, et al.

10 mentions

X 9
YouTube 1

View analytics →

ACR Open Rheumatol Mar 2023

Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study.

Christopher T Ritchlin, Atul Deodhar, Wolf-Henning Boehncke, et al.

6 mentions

X 2
YouTube 2
News 2

View analytics →

From PubMed

All publications

Searching PubMed…